243 related articles for article (PubMed ID: 6145440)
1. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
[TBL] [Abstract][Full Text] [Related]
2. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
Richards DA; Tuckman J; Prichard BN
Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
Elliott HL; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological basis for antihypertensive effects of intravenous labetalol.
Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
[TBL] [Abstract][Full Text] [Related]
5. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Riva E; Mennini T; Latini R
Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects of labetalol in man.
Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
[TBL] [Abstract][Full Text] [Related]
7. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
Kennedy I; Levy GP
Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
[TBL] [Abstract][Full Text] [Related]
8. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
[TBL] [Abstract][Full Text] [Related]
9. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
Drew GM; Hilditch A; Levy GP
Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
[TBL] [Abstract][Full Text] [Related]
10. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
11. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Tham TC; Guy S; McDermott BJ; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
[TBL] [Abstract][Full Text] [Related]
12. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
14. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
16. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
17. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
Lammintausta R; Koulu M; Allonen H
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Pandhi P; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma concentrations and pharmacological effects of labetalol.
Richards DA; Maconochie JG; Bland RE; Hopkins R; Woodings EP; Martin LE
Eur J Clin Pharmacol; 1977 Jan; 11(2):85-90. PubMed ID: 14010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
